Physician profile
Garry E Finke
NPI 1578890257
$262.73
in general payments reported to CMS, 2019-2025
6 companies · $79.69 in 2025
The $79.69 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.76 · 2020: $15.61 · 2021: $24.98 · 2022: $65.89 · 2024: $33.80 · 2025: $79.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.82 · Long Term Medical Supply Or Device Loan: $35.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.82 |
| Long Term Medical Supply Or Device Loan | $35.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $70.86 | 2019-2025 | Ozempic |
| Merck Sharp & Dohme LLC | $62.07 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $59.28 | 2019-2022 | |
| Baxter Healthcare | $35.67 | 2025 | Hillrom - Spot Vision Screener |
| Dexcom, INC. | $19.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.03 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garry Finke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.